收费全文 | 49670篇 |
免费 | 3782篇 |
国内免费 | 790篇 |
耳鼻咽喉 | 2283篇 |
儿科学 | 282篇 |
妇产科学 | 89篇 |
基础医学 | 2754篇 |
口腔科学 | 3220篇 |
临床医学 | 4269篇 |
内科学 | 1783篇 |
皮肤病学 | 538篇 |
神经病学 | 637篇 |
特种医学 | 2931篇 |
外国民族医学 | 4篇 |
外科学 | 18361篇 |
综合类 | 7749篇 |
现状与发展 | 1篇 |
预防医学 | 1579篇 |
眼科学 | 229篇 |
药学 | 2581篇 |
69篇 | |
中国医学 | 1658篇 |
肿瘤学 | 3225篇 |
2024年 | 149篇 |
2023年 | 865篇 |
2022年 | 1711篇 |
2021年 | 2137篇 |
2020年 | 2290篇 |
2019年 | 1876篇 |
2018年 | 1652篇 |
2017年 | 1816篇 |
2016年 | 2073篇 |
2015年 | 1896篇 |
2014年 | 3693篇 |
2013年 | 3538篇 |
2012年 | 3180篇 |
2011年 | 3445篇 |
2010年 | 2793篇 |
2009年 | 2731篇 |
2008年 | 2451篇 |
2007年 | 2473篇 |
2006年 | 2096篇 |
2005年 | 1978篇 |
2004年 | 1690篇 |
2003年 | 1291篇 |
2002年 | 1059篇 |
2001年 | 902篇 |
2000年 | 691篇 |
1999年 | 633篇 |
1998年 | 512篇 |
1997年 | 460篇 |
1996年 | 292篇 |
1995年 | 282篇 |
1994年 | 221篇 |
1993年 | 203篇 |
1992年 | 162篇 |
1991年 | 124篇 |
1990年 | 74篇 |
1989年 | 76篇 |
1988年 | 63篇 |
1987年 | 65篇 |
1986年 | 64篇 |
1985年 | 68篇 |
1984年 | 62篇 |
1983年 | 71篇 |
1982年 | 74篇 |
1981年 | 57篇 |
1980年 | 47篇 |
1979年 | 42篇 |
1978年 | 33篇 |
1977年 | 25篇 |
1976年 | 22篇 |
1975年 | 18篇 |
Materials and Methods: Relevant papers in PubMed published through June 2017 were selected to track updated information about PTL with an emphasis on diagnosis and novel therapeutic management.
Results: The most frequent cases include non-Hodgkin lymphoma derived from B-cells, mainly diffuse large B-cell lymphoma (DLBCL) followed by mucosa-associated lymphoid tissue (MALT) lymphoma or a mixed type. Other subtypes are less common. Lymphomas derived from T-cells and Hodgkin lymphomas are extremely rare. Hashimoto's autoimmune thyroiditis has been implicated as a risk factor for lymphoma. At the molecular level, the Wnt5a protein and its receptor Ror2 are involved in the course of the disease. Ultrasonography, fine needle aspiration (FNA) biopsy, and core or open biopsy combined with new diagnostic facilities contribute to an accurate diagnosis. An increased potential exists for a cure without the need for a radical surgical procedure. Modern chemoradiation therapy plus the monoclonal antibody rituximab, which acts against CD20, have limited the need for surgical interventions and provide an excellent outcome in most cases. However, some cases have resulted in treatment failure or recurrence.
Conclusions: A multidisciplinary approach must be used to define the management policy in each case. Future efforts by researchers are likely to be focused on the molecular level. 相似文献
Areas covered: Approximately 10–45% of patients undergoing head-and-neck cancers surgery develop SSIs. SSIs can lead to delayed wound healing, increased morbidity and mortality as well as costs. Consequently, SSIs need to be avoided where possible, as even the surgery itself impacts on patients’ subsequent activities and their quality of life, which is exacerbated by SSIs. Several risk factors for SSIs need to be considered to reduce future rates, and care is also needed in the selection and duration of antibiotic prophylaxis.
Expert commentary: Head and neck surgeons should give personalized care especially to patients at high risk of SSIs. Such patients include those who have had chemoradiotherapy and need reconstructive surgery, and patients from lower and middle-income countries and from poorer communities in high income countries, who often have high levels of co-morbidity because of resource constraints. 相似文献